nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—SLC47A1—Mitoxantrone—lymphatic system cancer	0.182	0.217	CbGbCtD
Cimetidine—SLC22A2—Cytarabine—lymphatic system cancer	0.0817	0.0973	CbGbCtD
Cimetidine—SLC22A1—Cytarabine—lymphatic system cancer	0.071	0.0845	CbGbCtD
Cimetidine—SLC22A3—Vincristine—lymphatic system cancer	0.0655	0.0779	CbGbCtD
Cimetidine—ABCB11—Vincristine—lymphatic system cancer	0.0602	0.0716	CbGbCtD
Cimetidine—CYP1A2—Carmustine—lymphatic system cancer	0.0365	0.0434	CbGbCtD
Cimetidine—SLC22A11—Methotrexate—lymphatic system cancer	0.0346	0.0412	CbGbCtD
Cimetidine—SLC22A7—Methotrexate—lymphatic system cancer	0.033	0.0392	CbGbCtD
Cimetidine—CYP3A5—Teniposide—lymphatic system cancer	0.0329	0.0392	CbGbCtD
Cimetidine—CYP2E1—Mitoxantrone—lymphatic system cancer	0.0296	0.0353	CbGbCtD
Cimetidine—CYP2C19—Teniposide—lymphatic system cancer	0.0266	0.0316	CbGbCtD
Cimetidine—CYP2C9—Teniposide—lymphatic system cancer	0.0221	0.0263	CbGbCtD
Cimetidine—CYP3A7—Vincristine—lymphatic system cancer	0.0211	0.0251	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0211	0.0251	CbGbCtD
Cimetidine—SLC22A8—Methotrexate—lymphatic system cancer	0.0201	0.024	CbGbCtD
Cimetidine—CYP3A5—Vincristine—lymphatic system cancer	0.0158	0.0189	CbGbCtD
Cimetidine—ABCB1—Mitoxantrone—lymphatic system cancer	0.015	0.0178	CbGbCtD
Cimetidine—Immunocompromised—Fludarabine—lymphatic system cancer	0.014	0.0879	CcSEcCtD
Cimetidine—SLC22A6—Methotrexate—lymphatic system cancer	0.014	0.0167	CbGbCtD
Cimetidine—CYP3A4—Cytarabine—lymphatic system cancer	0.013	0.0155	CbGbCtD
Cimetidine—CYP3A4—Teniposide—lymphatic system cancer	0.0128	0.0153	CbGbCtD
Cimetidine—ABCB1—Vincristine—lymphatic system cancer	0.0103	0.0123	CbGbCtD
Cimetidine—Immunodeficiency—Fludarabine—lymphatic system cancer	0.0102	0.0635	CcSEcCtD
Cimetidine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.00898	0.0107	CbGbCtD
Cimetidine—Hepatic fibrosis—Methotrexate—lymphatic system cancer	0.00867	0.0542	CcSEcCtD
Cimetidine—ABCB1—Methotrexate—lymphatic system cancer	0.00624	0.00743	CbGbCtD
Cimetidine—CYP3A4—Vincristine—lymphatic system cancer	0.00618	0.00736	CbGbCtD
Cimetidine—Hepatic insufficiency—Methotrexate—lymphatic system cancer	0.00338	0.0211	CcSEcCtD
Cimetidine—Immunodeficiency—Methotrexate—lymphatic system cancer	0.00301	0.0188	CcSEcCtD
Cimetidine—Bone marrow depression—Teniposide—lymphatic system cancer	0.00297	0.0186	CcSEcCtD
Cimetidine—Bone marrow depression—Fludarabine—lymphatic system cancer	0.00261	0.0163	CcSEcCtD
Cimetidine—Necrolysis epidermal—Methotrexate—lymphatic system cancer	0.0023	0.0144	CcSEcCtD
Cimetidine—Sinus bradycardia—Mitoxantrone—lymphatic system cancer	0.00214	0.0134	CcSEcCtD
Cimetidine—White blood cell count decreased—Mitoxantrone—lymphatic system cancer	0.00211	0.0132	CcSEcCtD
Cimetidine—Allergic cutaneous angiitis—Methotrexate—lymphatic system cancer	0.00164	0.0103	CcSEcCtD
Cimetidine—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.00162	0.0101	CcSEcCtD
Cimetidine—Bone marrow depression—Vincristine—lymphatic system cancer	0.00159	0.00997	CcSEcCtD
Cimetidine—Bone marrow depression—Mitoxantrone—lymphatic system cancer	0.00155	0.00971	CcSEcCtD
Cimetidine—Hepatotoxicity—Carmustine—lymphatic system cancer	0.00146	0.00913	CcSEcCtD
Cimetidine—Hepatic failure—Fludarabine—lymphatic system cancer	0.00142	0.0089	CcSEcCtD
Cimetidine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00142	0.00888	CcSEcCtD
Cimetidine—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00129	0.00808	CcSEcCtD
Cimetidine—Alopecia—Mechlorethamine—lymphatic system cancer	0.00121	0.00755	CcSEcCtD
Cimetidine—Pancytopenia—Teniposide—lymphatic system cancer	0.00119	0.00747	CcSEcCtD
Cimetidine—Neutropenia—Teniposide—lymphatic system cancer	0.00118	0.00736	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.00115	0.0072	CcSEcCtD
Cimetidine—Musculoskeletal pain—Vincristine—lymphatic system cancer	0.00109	0.00682	CcSEcCtD
Cimetidine—Leukocytoclastic vasculitis—Methotrexate—lymphatic system cancer	0.00106	0.00666	CcSEcCtD
Cimetidine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00106	0.00666	CcSEcCtD
Cimetidine—Pancytopenia—Fludarabine—lymphatic system cancer	0.00105	0.00657	CcSEcCtD
Cimetidine—Disorientation—Bleomycin—lymphatic system cancer	0.00105	0.00656	CcSEcCtD
Cimetidine—Neutropenia—Fludarabine—lymphatic system cancer	0.00103	0.00647	CcSEcCtD
Cimetidine—Gynaecomastia—Carmustine—lymphatic system cancer	0.00101	0.00631	CcSEcCtD
Cimetidine—Pneumonia—Fludarabine—lymphatic system cancer	0.000991	0.0062	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.000977	0.00611	CcSEcCtD
Cimetidine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00097	0.00607	CcSEcCtD
Cimetidine—Renal failure—Fludarabine—lymphatic system cancer	0.000969	0.00606	CcSEcCtD
Cimetidine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00095	0.00594	CcSEcCtD
Cimetidine—Alopecia—Teniposide—lymphatic system cancer	0.00089	0.00556	CcSEcCtD
Cimetidine—Hepatic failure—Vincristine—lymphatic system cancer	0.000869	0.00544	CcSEcCtD
Cimetidine—Erythema multiforme—Fludarabine—lymphatic system cancer	0.000837	0.00523	CcSEcCtD
Cimetidine—Agitation—Teniposide—lymphatic system cancer	0.000805	0.00504	CcSEcCtD
Cimetidine—Leukopenia—Teniposide—lymphatic system cancer	0.000784	0.00491	CcSEcCtD
Cimetidine—Alopecia—Fludarabine—lymphatic system cancer	0.000782	0.00489	CcSEcCtD
Cimetidine—Bone marrow depression—Methotrexate—lymphatic system cancer	0.000774	0.00484	CcSEcCtD
Cimetidine—Pancytopenia—Bleomycin—lymphatic system cancer	0.00077	0.00481	CcSEcCtD
Cimetidine—Urinary retention—Vincristine—lymphatic system cancer	0.000743	0.00465	CcSEcCtD
Cimetidine—Pneumonia—Bleomycin—lymphatic system cancer	0.000727	0.00455	CcSEcCtD
Cimetidine—Confusional state—Teniposide—lymphatic system cancer	0.000721	0.00451	CcSEcCtD
Cimetidine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.000715	0.00447	CcSEcCtD
Cimetidine—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.000713	0.00446	CcSEcCtD
Cimetidine—Agitation—Fludarabine—lymphatic system cancer	0.000708	0.00443	CcSEcCtD
Cimetidine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.0007	0.00438	CcSEcCtD
Cimetidine—Tachycardia—Teniposide—lymphatic system cancer	0.000698	0.00437	CcSEcCtD
Cimetidine—Malaise—Fludarabine—lymphatic system cancer	0.000695	0.00434	CcSEcCtD
Cimetidine—Leukopenia—Fludarabine—lymphatic system cancer	0.000689	0.00431	CcSEcCtD
Cimetidine—Hepatotoxicity—Methotrexate—lymphatic system cancer	0.000676	0.00423	CcSEcCtD
Cimetidine—Pancytopenia—Carmustine—lymphatic system cancer	0.000672	0.0042	CcSEcCtD
Cimetidine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000664	0.00415	CcSEcCtD
Cimetidine—Neutropenia—Carmustine—lymphatic system cancer	0.000661	0.00414	CcSEcCtD
Cimetidine—Arthralgia—Fludarabine—lymphatic system cancer	0.000656	0.0041	CcSEcCtD
Cimetidine—Myalgia—Fludarabine—lymphatic system cancer	0.000656	0.0041	CcSEcCtD
Cimetidine—Pancytopenia—Vincristine—lymphatic system cancer	0.000641	0.00401	CcSEcCtD
Cimetidine—Pneumonia—Carmustine—lymphatic system cancer	0.000634	0.00397	CcSEcCtD
Cimetidine—Confusional state—Fludarabine—lymphatic system cancer	0.000634	0.00396	CcSEcCtD
Cimetidine—Neutropenia—Vincristine—lymphatic system cancer	0.000631	0.00395	CcSEcCtD
Cimetidine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.000629	0.00393	CcSEcCtD
Cimetidine—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000625	0.00391	CcSEcCtD
Cimetidine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.000622	0.00389	CcSEcCtD
Cimetidine—Renal failure—Carmustine—lymphatic system cancer	0.00062	0.00388	CcSEcCtD
Cimetidine—Vomiting—Mechlorethamine—lymphatic system cancer	0.000617	0.00386	CcSEcCtD
Cimetidine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000615	0.00385	CcSEcCtD
Cimetidine—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000615	0.00385	CcSEcCtD
Cimetidine—Rash—Mechlorethamine—lymphatic system cancer	0.000612	0.00383	CcSEcCtD
Cimetidine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000611	0.00382	CcSEcCtD
Cimetidine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.000606	0.00379	CcSEcCtD
Cimetidine—Pneumonia—Vincristine—lymphatic system cancer	0.000606	0.00379	CcSEcCtD
Cimetidine—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00059	0.00369	CcSEcCtD
Cimetidine—Feeling abnormal—Teniposide—lymphatic system cancer	0.000589	0.00369	CcSEcCtD
Cimetidine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.000586	0.00367	CcSEcCtD
Cimetidine—Renal failure—Mitoxantrone—lymphatic system cancer	0.000576	0.00361	CcSEcCtD
Cimetidine—Nausea—Mechlorethamine—lymphatic system cancer	0.000576	0.0036	CcSEcCtD
Cimetidine—Alopecia—Bleomycin—lymphatic system cancer	0.000573	0.00359	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000573	0.00358	CcSEcCtD
Cimetidine—Body temperature increased—Teniposide—lymphatic system cancer	0.000565	0.00354	CcSEcCtD
Cimetidine—Hallucination—Carmustine—lymphatic system cancer	0.000563	0.00352	CcSEcCtD
Cimetidine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000547	0.00342	CcSEcCtD
Cimetidine—Fatigue—Fludarabine—lymphatic system cancer	0.000542	0.00339	CcSEcCtD
Cimetidine—Hallucination—Vincristine—lymphatic system cancer	0.000538	0.00336	CcSEcCtD
Cimetidine—Constipation—Fludarabine—lymphatic system cancer	0.000538	0.00336	CcSEcCtD
Cimetidine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000536	0.00335	CcSEcCtD
Cimetidine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000527	0.0033	CcSEcCtD
Cimetidine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000526	0.00329	CcSEcCtD
Cimetidine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000518	0.00324	CcSEcCtD
Cimetidine—Asthenia—Teniposide—lymphatic system cancer	0.000513	0.00321	CcSEcCtD
Cimetidine—Malaise—Bleomycin—lymphatic system cancer	0.000509	0.00319	CcSEcCtD
Cimetidine—Leukopenia—Bleomycin—lymphatic system cancer	0.000505	0.00316	CcSEcCtD
Cimetidine—Alopecia—Carmustine—lymphatic system cancer	0.0005	0.00313	CcSEcCtD
Cimetidine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000497	0.00311	CcSEcCtD
Cimetidine—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00049	0.00307	CcSEcCtD
Cimetidine—Diarrhoea—Teniposide—lymphatic system cancer	0.000489	0.00306	CcSEcCtD
Cimetidine—Myalgia—Bleomycin—lymphatic system cancer	0.000481	0.00301	CcSEcCtD
Cimetidine—Alopecia—Vincristine—lymphatic system cancer	0.000478	0.00299	CcSEcCtD
Cimetidine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000467	0.00292	CcSEcCtD
Cimetidine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000465	0.00291	CcSEcCtD
Cimetidine—Confusional state—Bleomycin—lymphatic system cancer	0.000465	0.00291	CcSEcCtD
Cimetidine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000463	0.0029	CcSEcCtD
Cimetidine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000461	0.00288	CcSEcCtD
Cimetidine—Vomiting—Teniposide—lymphatic system cancer	0.000455	0.00284	CcSEcCtD
Cimetidine—Agitation—Carmustine—lymphatic system cancer	0.000453	0.00283	CcSEcCtD
Cimetidine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000451	0.00282	CcSEcCtD
Cimetidine—Asthenia—Fludarabine—lymphatic system cancer	0.000451	0.00282	CcSEcCtD
Cimetidine—Rash—Teniposide—lymphatic system cancer	0.000451	0.00282	CcSEcCtD
Cimetidine—Dermatitis—Teniposide—lymphatic system cancer	0.000451	0.00282	CcSEcCtD
Cimetidine—Headache—Teniposide—lymphatic system cancer	0.000448	0.0028	CcSEcCtD
Cimetidine—Leukopenia—Carmustine—lymphatic system cancer	0.000441	0.00276	CcSEcCtD
Cimetidine—Agitation—Vincristine—lymphatic system cancer	0.000432	0.0027	CcSEcCtD
Cimetidine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00043	0.00269	CcSEcCtD
Cimetidine—Nausea—Teniposide—lymphatic system cancer	0.000425	0.00266	CcSEcCtD
Cimetidine—Hepatic failure—Methotrexate—lymphatic system cancer	0.000422	0.00264	CcSEcCtD
Cimetidine—Leukopenia—Vincristine—lymphatic system cancer	0.000421	0.00263	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00042	0.00263	CcSEcCtD
Cimetidine—Myalgia—Carmustine—lymphatic system cancer	0.00042	0.00263	CcSEcCtD
Cimetidine—Anxiety—Carmustine—lymphatic system cancer	0.000418	0.00262	CcSEcCtD
Cimetidine—Malaise—Mitoxantrone—lymphatic system cancer	0.000413	0.00259	CcSEcCtD
Cimetidine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00041	0.00257	CcSEcCtD
Cimetidine—Confusional state—Carmustine—lymphatic system cancer	0.000406	0.00254	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000402	0.00251	CcSEcCtD
Cimetidine—Myalgia—Vincristine—lymphatic system cancer	0.000401	0.00251	CcSEcCtD
Cimetidine—Vomiting—Fludarabine—lymphatic system cancer	0.0004	0.0025	CcSEcCtD
Cimetidine—Rash—Fludarabine—lymphatic system cancer	0.000396	0.00248	CcSEcCtD
Cimetidine—Dermatitis—Fludarabine—lymphatic system cancer	0.000396	0.00248	CcSEcCtD
Cimetidine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000394	0.00246	CcSEcCtD
Cimetidine—Headache—Fludarabine—lymphatic system cancer	0.000394	0.00246	CcSEcCtD
Cimetidine—Tachycardia—Carmustine—lymphatic system cancer	0.000393	0.00246	CcSEcCtD
Cimetidine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00039	0.00244	CcSEcCtD
Cimetidine—Myalgia—Mitoxantrone—lymphatic system cancer	0.00039	0.00244	CcSEcCtD
Cimetidine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000389	0.00243	CcSEcCtD
Cimetidine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000384	0.0024	CcSEcCtD
Cimetidine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00038	0.00238	CcSEcCtD
Cimetidine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000377	0.00236	CcSEcCtD
Cimetidine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000376	0.00235	CcSEcCtD
Cimetidine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000374	0.00234	CcSEcCtD
Cimetidine—Nausea—Fludarabine—lymphatic system cancer	0.000373	0.00234	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000367	0.00229	CcSEcCtD
Cimetidine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000366	0.00229	CcSEcCtD
Cimetidine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000365	0.00228	CcSEcCtD
Cimetidine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000364	0.00228	CcSEcCtD
Cimetidine—Somnolence—Carmustine—lymphatic system cancer	0.000358	0.00224	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00035	0.00219	CcSEcCtD
Cimetidine—Constipation—Carmustine—lymphatic system cancer	0.000344	0.00215	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000341	0.00214	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000341	0.00213	CcSEcCtD
Cimetidine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00034	0.00212	CcSEcCtD
Cimetidine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000332	0.00208	CcSEcCtD
Cimetidine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000331	0.00207	CcSEcCtD
Cimetidine—Fatigue—Vincristine—lymphatic system cancer	0.000331	0.00207	CcSEcCtD
Cimetidine—Asthenia—Bleomycin—lymphatic system cancer	0.000331	0.00207	CcSEcCtD
Cimetidine—Constipation—Vincristine—lymphatic system cancer	0.000328	0.00205	CcSEcCtD
Cimetidine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000322	0.00202	CcSEcCtD
Cimetidine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000321	0.00201	CcSEcCtD
Cimetidine—Constipation—Mitoxantrone—lymphatic system cancer	0.00032	0.002	CcSEcCtD
Cimetidine—Body temperature increased—Carmustine—lymphatic system cancer	0.000318	0.00199	CcSEcCtD
Cimetidine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000311	0.00195	CcSEcCtD
Cimetidine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000308	0.00193	CcSEcCtD
Cimetidine—Neutropenia—Methotrexate—lymphatic system cancer	0.000306	0.00192	CcSEcCtD
Cimetidine—Body temperature increased—Vincristine—lymphatic system cancer	0.000304	0.0019	CcSEcCtD
Cimetidine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000302	0.00189	CcSEcCtD
Cimetidine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000296	0.00185	CcSEcCtD
Cimetidine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000296	0.00185	CcSEcCtD
Cimetidine—Pneumonia—Methotrexate—lymphatic system cancer	0.000294	0.00184	CcSEcCtD
Cimetidine—Vomiting—Bleomycin—lymphatic system cancer	0.000293	0.00183	CcSEcCtD
Cimetidine—Drowsiness—Methotrexate—lymphatic system cancer	0.000292	0.00183	CcSEcCtD
Cimetidine—Rash—Bleomycin—lymphatic system cancer	0.000291	0.00182	CcSEcCtD
Cimetidine—Dermatitis—Bleomycin—lymphatic system cancer	0.00029	0.00182	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00029	0.00181	CcSEcCtD
Cimetidine—Asthenia—Carmustine—lymphatic system cancer	0.000289	0.00181	CcSEcCtD
Cimetidine—Renal failure—Methotrexate—lymphatic system cancer	0.000287	0.0018	CcSEcCtD
Cimetidine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000283	0.00177	CcSEcCtD
Cimetidine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000276	0.00172	CcSEcCtD
Cimetidine—Asthenia—Vincristine—lymphatic system cancer	0.000276	0.00172	CcSEcCtD
Cimetidine—Diarrhoea—Carmustine—lymphatic system cancer	0.000275	0.00172	CcSEcCtD
Cimetidine—Nausea—Bleomycin—lymphatic system cancer	0.000274	0.00171	CcSEcCtD
Cimetidine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000273	0.00171	CcSEcCtD
Cimetidine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000268	0.00168	CcSEcCtD
Cimetidine—Dizziness—Carmustine—lymphatic system cancer	0.000266	0.00166	CcSEcCtD
Cimetidine—Diarrhoea—Vincristine—lymphatic system cancer	0.000263	0.00164	CcSEcCtD
Cimetidine—Hepatitis—Methotrexate—lymphatic system cancer	0.000262	0.00164	CcSEcCtD
Cimetidine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000256	0.0016	CcSEcCtD
Cimetidine—Vomiting—Carmustine—lymphatic system cancer	0.000256	0.0016	CcSEcCtD
Cimetidine—Dizziness—Vincristine—lymphatic system cancer	0.000254	0.00159	CcSEcCtD
Cimetidine—Rash—Carmustine—lymphatic system cancer	0.000254	0.00159	CcSEcCtD
Cimetidine—Dermatitis—Carmustine—lymphatic system cancer	0.000253	0.00159	CcSEcCtD
Cimetidine—Headache—Carmustine—lymphatic system cancer	0.000252	0.00158	CcSEcCtD
Cimetidine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000248	0.00155	CcSEcCtD
Cimetidine—Vomiting—Vincristine—lymphatic system cancer	0.000244	0.00153	CcSEcCtD
Cimetidine—Rash—Vincristine—lymphatic system cancer	0.000242	0.00151	CcSEcCtD
Cimetidine—Dermatitis—Vincristine—lymphatic system cancer	0.000242	0.00151	CcSEcCtD
Cimetidine—Headache—Vincristine—lymphatic system cancer	0.000241	0.0015	CcSEcCtD
Cimetidine—Nausea—Carmustine—lymphatic system cancer	0.000239	0.00149	CcSEcCtD
Cimetidine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000238	0.00149	CcSEcCtD
Cimetidine—Rash—Mitoxantrone—lymphatic system cancer	0.000236	0.00148	CcSEcCtD
Cimetidine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000236	0.00147	CcSEcCtD
Cimetidine—Headache—Mitoxantrone—lymphatic system cancer	0.000234	0.00147	CcSEcCtD
Cimetidine—Alopecia—Methotrexate—lymphatic system cancer	0.000232	0.00145	CcSEcCtD
Cimetidine—Nausea—Vincristine—lymphatic system cancer	0.000228	0.00143	CcSEcCtD
Cimetidine—Nausea—Mitoxantrone—lymphatic system cancer	0.000222	0.00139	CcSEcCtD
Cimetidine—Malaise—Methotrexate—lymphatic system cancer	0.000206	0.00129	CcSEcCtD
Cimetidine—Leukopenia—Methotrexate—lymphatic system cancer	0.000204	0.00128	CcSEcCtD
Cimetidine—Arthralgia—Methotrexate—lymphatic system cancer	0.000194	0.00122	CcSEcCtD
Cimetidine—Myalgia—Methotrexate—lymphatic system cancer	0.000194	0.00122	CcSEcCtD
Cimetidine—Confusional state—Methotrexate—lymphatic system cancer	0.000188	0.00118	CcSEcCtD
Cimetidine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000186	0.00117	CcSEcCtD
Cimetidine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000182	0.00114	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00017	0.00106	CcSEcCtD
Cimetidine—Somnolence—Methotrexate—lymphatic system cancer	0.000166	0.00104	CcSEcCtD
Cimetidine—Fatigue—Methotrexate—lymphatic system cancer	0.000161	0.001	CcSEcCtD
Cimetidine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000154	0.000961	CcSEcCtD
Cimetidine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000147	0.000921	CcSEcCtD
Cimetidine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000137	0.000859	CcSEcCtD
Cimetidine—Asthenia—Methotrexate—lymphatic system cancer	0.000134	0.000836	CcSEcCtD
Cimetidine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000127	0.000798	CcSEcCtD
Cimetidine—Dizziness—Methotrexate—lymphatic system cancer	0.000123	0.000771	CcSEcCtD
Cimetidine—Vomiting—Methotrexate—lymphatic system cancer	0.000118	0.000741	CcSEcCtD
Cimetidine—Rash—Methotrexate—lymphatic system cancer	0.000117	0.000735	CcSEcCtD
Cimetidine—Dermatitis—Methotrexate—lymphatic system cancer	0.000117	0.000734	CcSEcCtD
Cimetidine—Headache—Methotrexate—lymphatic system cancer	0.000117	0.00073	CcSEcCtD
Cimetidine—Nausea—Methotrexate—lymphatic system cancer	0.000111	0.000692	CcSEcCtD
